Details of the Drug | DrugMAP

General Information of Drug (ID: DMUCD9F)

Drug Name

INT131

Synonyms

C541917000

Indication

Disease Entry	ICD 11	Status	REF
Type-2 diabetes	5A11	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C21H12Cl4N2O3S
Canonical SMILES: C1=CC=C2C(=C1)C=C(C=N2)OC3=C(C=C(C=C3Cl)NS(=O)(=O)C4=C(C=C(C=C4)Cl)Cl)Cl
InChI: 1S/C21H12Cl4N2O3S/c22-13-5-6-20(16(23)8-13)31(28,29)27-14-9-17(24)21(18(25)10-14)30-15-7-12-3-1-2-4-19(12)26-11-15/h1-11,27H
InChIKey: NMRWDFUZLLQSBN-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 10229498
CAS Number: 315224-26-1
TTD ID: D06QBY

References

1	ClinicalTrials.gov (NCT00631007) A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator. U.S. National Institutes of Health.